文献速递主动脉疾病

遗传性胸主动脉疾病腔内修复现状

The Current State of Endovascular Aortic Repair in Heritable Thoracic Aortic Disease.
PubMed 文献 · Ann Vasc Surg · 2026-02-26

综述遗传性胸主动脉疾病(HTAD)患者腔内主动脉修复(EVAR)的现状。HTAD患者发病年轻、主动脉相关死亡风险高,传统开放手术并发症多。EVAR已从胸主动脉EVAR扩展至弓部及胸腹主动脉开窗分支EVAR,近期技术成功率高、围术期并发症低。EVICTUS研究(n=171)显示马凡综合征与Loeys-Dietz综合征患者中期生存与开放修复相似,但过半需二次干预。指南目前仅推荐EVAR用于急诊桥接或避免开放手术的再手术野。

要点

  • HTAD患者主动脉事件年轻化,早期识别和筛查可改善长期生存。
  • EVAR在HTAD中技术成功率高、围术期并发症低,但二次干预率较高。
  • 指南目前仅推荐EVAR用于急诊桥接或避免开放手术的再手术野。

核心结论

  • EVAR在HTAD中近期技术成功率高、围术期并发症低,但长期结局仍需与开放修复比较后方可推荐。
  • 指南目前仅建议EVAR用于急诊桥接或避免开放手术的再手术野。

研究设计与样本

  • 综述,总结HTAD中EVAR的演变与当代数据,并引用EVICTUS研究(n=171)的中期结局。

主要发现

  • EVAR在HTAD已从胸主动脉EVAR扩展至弓部及胸腹主动脉开窗分支EVAR。
  • 当代数据显示EVAR在HTAD中技术成功率高、围术期并发症低。
  • EVICTUS研究(n=171)中马凡综合征与Loeys-Dietz综合征患者中期生存(中位随访4.7年)与开放修复相似。
  • EVICTUS研究中过半患者需二次干预以维持瘤囊隔绝,但研究期间开放转换率低。

关键数值与推荐

  • 指南目前建议EVAR在HTAD中仅用于急诊干预作为开放修复的桥接,或用于再手术野中避免开放手术。
  • EVICTUS研究纳入遗传性主动脉病患者n=171,中位随访4.7年。

临床怎么用

  • HTAD的广泛主动脉修复倾向采用分期策略,常结合开放与腔内技术。
  • 需在高容量中心由精通开放与腔内技术的多学科主动脉团队实施。
  • 腔内移植物技术与植入技术需持续演进并针对HTAD人群个体化。

局限性

  • EVAR在HTAD中的长期结局尚未明确,需与开放修复比较。
  • EVICTUS研究为中期随访(中位4.7年),二次干预率较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heritable thoracic aortic disease (HTAD) is associated with the development of aortic aneurysms or dissections. These patients often suffer their initial aortic event at a younger age, compared to those without HTADs. Although genetic aortopathy can affect any segment of the aorta, there are characteristic segments for specific HTADs. This population is at increased risk of aortic-related mortality, and early identification and screening of HTAD has been shown to positively impact long-term survival. The standard of aortic care in this population has historically involved open repair. However, the associated morbidity and mortality of open thoracoabdominal aortic repair led to the expansion of endovascular aortic repair (EVAR) in HTAD, despite concerns of chronic radial force from the aortic endograft and the bridging stents to the renovisceral target vessels. EVAR in HTAD has evolved from thoracic EVAR in a prior open thoracic graft to fenestrated-branched EVAR of the aortic arch and thoracoabdominal aorta. Contemporary data demonstrate high technical success and low perioperative morbidity. The EVICTUS study elucidated midterm outcomes of endovascular repair in genetic aortopathy (n = 171) with similar midterm survival (median follow-up 4.7 years) in patients with Marfan syndrome and Loeys-Dietz syndrome, compared to open repair. Despite over half of patients undergoing secondary interventions to maintain sac exclusion, there was a low rate of open conversion during the study period. Guidelines currently advise endovascular repair in HTAD only in emergent interventions as a bridge to open repair or to avoid open surgery in reoperative fields. Long-term outcomes must be defined and compared to open repair if endovascular repair in HTAD is to ever be recommended in the guidelines. Staged strategies are now preferred for these extensive aortic repairs in HTAD, often combining open and endovascular techniques. Thus, multidisciplinary aortic teams with expertise in both techniques at high-volume centers are essential. Finally, endograft technology and implantation techniques must continue to evolve and to be tailored to this unique population.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Aru RG, Haulon S, Black JH, et al. The Current State of Endovascular Aortic Repair in Heritable Thoracic Aortic Disease. Ann Vasc Surg. 2026. PMID: 41759888. doi:10.1016/j.avsg.2026.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。